Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SMIM10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
XPO7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR3945HG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
TXNDC15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBE2D3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MED20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AMMECR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MS4A14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF890P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PGM2L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM39A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARL2BP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MPL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TM4SF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF277 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on